Print ISSN: 2581-5725
Online ISSN: 2456-9267
CODEN : IACHCL
IP Archives of Cytology and Histopathology Research (ACHR) open access, peer-reviewed quarterly journal publishing since 2016 and is published under the Khyati Education and Research Foundation (KERF), is registered as a non-profit society (under the society registration act, 1860), Government of India with the vision of various accredited vocational courses in healthcare, education, paramedical, yoga, publication, teaching and research activity, with the aim of faster and better dissemination of knowledge, we will be publishing the article more...Case Report
Author Details :
Volume : 6, Issue : 1, Year : 2021
Article Page : 64-67
https://doi.org/10.18231/j.achr.2021.016
Abstract
Inflammatory pseudotumor of fallopian tube is an uncommon benign lesion. We report a case of an inflammatory pseudotumor of left fallopian tube in a 29 year-old woman. She presented with pain in lower abdomen, urinary frequency and dysuria. Contrast enhanced computerized tomography revealed a large necrotic mass in left adnexa abutting superior wall of urinary bladder and lower anterior wall of uterus. Left ovary was seen adherent to the posterior part of the mass. Serum CA-125 was within normal
limit. The patient underwent tru-cut biopsy and subsequent excision of left adnexal mass. Histopathology revealed an inflammatory pseudotumor. We reviewed the clinical, imaging and pathological features of the inflammatory pseudotumor of fallopian tube and discussed its differential diagnosis.
Keywords: Inflammatory, Pseudotumour, Fallopian Tube, Diagnosis, and Immunohistochemistry.
How to cite : Gupta A , Mishra S C, Rao R N, Kapoor D , Inflammatory pseudotumor of fallopian tube: A case report with review of literature. IP Arch Cytol Histopathol Res 2021;6(1):64-67
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.